Endurant Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Endurant Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-158,721	Closed	-$11.3M	–	58
2022 Q3	$11.3M	Buy	+158,721	New	+$11.5M	3.67%	10
2022 Q2	–	Sell	-194,684	Closed	-$14.2M	–	56
2022 Q1	$14.2M	Buy	+194,684	New	+$13.1M	3.75%	6
2021 Q4	–	Sell	-211,821	Closed	-$12.5M	–	72
2021 Q3	$12.5M	Buy	211,821 +110,740	+110%	+$7.29M	2.85%	9
2021 Q2	$6.75M	Sell	101,081 -132,817	-57%	-$8.66M	1.86%	20
2021 Q1	$14.8M	Sell	233,898 -10,168	-4%	-$633K	3.85%	4
2020 Q4	$15.1M	Sell	244,066 -146,090	-37%	-$8.98M	5.46%	3
2020 Q3	$23.5M	Buy	390,156 +354,047	+980%	+$21.3M	6.96%	2
2020 Q2	$2.12M	Sell	36,109 -100,816	-74%	-$6.03M	0.12%	39
2020 Q1	$7.63M	Sell	136,925 -264,509	-66%	-$16.2M	3.46%	11
2019 Q4	$25.8M	Buy	401,434 +109,509	+38%	+$6.27M	8.12%	1
2019 Q3	$14.8M	Buy	291,925 +205,628	+238%	+$9.66M	5.31%	7
2019 Q2	$3.91M	Sell	86,297 -204,984	-70%	-$9.55M	1.54%	28
2019 Q1	$13.9M	Buy	291,281 +241,944	+490%	+$12.1M	5.49%	1
2018 Q4	$2.56M	Sell	49,337 -28,634	-37%	-$1.54M	1.36%	23
2018 Q3	$4.84M	Buy	+77,971	New	+$4.63M	2.15%	15

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Endurant Capital Management's BMY Position: Q4 2022 in Review

Endurant Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 158,721 shares — an estimated $11.3M sold.

Endurant Capital Management first reported a position in BMY in Q3 2018 and held it in 15 quarters. The position peaked at $25.8M in Q4 2019. 2,601 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

Endurant Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
Endurant Capital Management sold 158,721 Bristol-Myers Squibb shares in Q4 2022, an estimated $11.3M.
Endurant Capital Management first reported a position in Bristol-Myers Squibb in Q3 2018 and held it in 15 quarters.
Endurant Capital Management's Bristol-Myers Squibb position peaked at $25.8M in Q4 2019.
2,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Endurant Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.